LACOG - Latin American Cooperative Oncology Group· @LACOG_group · X·· 2 天前评分45
正文 · 原文
On October 23, LACOG investigator Dr. Gustavo Werutsky presented patient-reported outcomes (PROs) from the phase III lidERA trial at ESMO Congress 2026 in Madrid, highlighting quality of life and treatment tolerability in early breast cancer.
#LACOG #ESMO2026
30 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
Genomic biomarkers of response to extreme bipolar androgen therapy (BAT) alternating darolutamide in metastatic castration-resistant prostate cancer: An ancillary biomarker analysis of the ExBAT/LACOG 0620 trial
https://esmocongress.esmo.org来源：LACOG - Latin American Cooperative Oncology Group · x.com